To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594

NCT01636024 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety
Pharmacokinetics
Pharmacodynamics of AZD7594

Interventions

DRUG: AZD7594
DRUG: Placebo to match

Sponsor

AstraZeneca